Acute Heart Failure Syndromes: Current State and Framework for Future Research

By M. Gheorghiade, F. Zannad, G. Sopko, L. Klein, I. Piña, M. Konstam, B. Massie, E. Roland, S. Targum, S. Collins and 2 more. Circulation, 2005

773 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/891fd8d9e7d284a00f8ad0e642836702175381c0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Gerasimos Filippatos
2. M. Gheorghiade
3. L. Tavazzi
4. J. Udelson
5. S. Anker
6. D. Brutsaert
7. M. Drazner
8. D. Avers

Citations in the corpus

• Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine (2010, background): “Previous scores have used only clinical examination to evaluate congestion.34,110 We propose that a combination of available measurements of congestion be prospectively tested for their ability to predict re-hospitalization after admission for AHF.”
• Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. (2007, background): “Nevertheless, thenumberof annual hospitalizations for HF continues to rise, and mortality rates among patients hospitalized with HF remain high.(1-7) To date, no treatment initiated at the time of hospitalization for acute decompensated HF has been found to improve clinical outcomes.”
• EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. (2006, result): “A recent paper described AHF patients treated in cardiology wards in Italy, which had more selected and severe patient population (nearly half with pulmonary oedema) compared with the present study.16 In EHFS II, the mean age was similar to previous surveys and registries of AHF patients both in Eur”
• Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. (2006, neutral): “Other intravenous vasodilator 1650 (3) 170 (3)”
• Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. (2007, background): “A considerable share of the burden of HF is accounted for by the acute HF syndromes (AHFS), defined as conditions with gradual or rapid changes in the signs and symptoms of HF that require urgent therapy.(2) Patients hospitalized with AHFS have poor overall prognosis.”